PharmaCom BioVet Inc. (PHMB)

[uglygreenalien]

News...

PharmaCom BioVet, Inc. Announces Corporate Vision to Research, Treat and
Compassionately Care for Companion Animals Afflicted With Cancer


RALEIGH, NC, Oct 07, 2008 (MARKET WIRE via COMTEX) -- PharmaCom BioVet, Inc.
(PINKSHEETS: PHMB) is pleased to announce their corporate vision to research,
treat and compassionately care for companion animals afflicted with cancer.

PharmaCom BioVet, Inc. is dedicated to advancing the medical care industry for
companion animals by establishing state-of-the-art treatment centers for
lymphoma and other forms of cancer throughout the country. The company's focus
is on furthering cancer research, treatment and care for companion animals.
Their primary goals include creating compassionate care facilities to treat
animals afflicted with cancer and to find products in conjunction with
procedures that will eradicate cancer in companion animals.

"Our ultimate goal is to work towards a day when we can eradicate cancer in
companion animals as we utilize our personal and professional relationships to
create a think tank of the brightest minds in the veterinary and university
fields to advance research and technology, all while focusing on compassionate
care," said Gary S. Berthold, Founder and CEO of PharmaCom BioVet.

With 75 million dogs in the United State alone, Americans spend $9.8 Billion a
year on veterinary services. Cancer is the number one cause of death in dogs,
with one out of every three dogs being diagnosed with cancer and 50% of those
dogs will succumb to their illness.

In response to demand and the current lack of adequate cancer treatment options
and facilities for animal lovers whose pets are suffering from cancer, PharmaCom
BioVet intends to open a network of companion animal cancer care centers
throughout North America.

About PharmaCom BioVet, Inc.:

PharmaCom BioVet, Inc. is dedicated to advancing the medical care industry for
companion animals by establishing state-of-the-art treatment centers for
lymphoma and other forms of cancer throughout the country. The purpose of these
centers is to help prolong the quality of life for companion animals with cancer
and pursue the potential for complete cure. These centers will also operate
under the philosophy of providing a compassionate care environment for both
companion animal patients and their owners. For more information, please visit
our website www.PharmaComBioVet.com.

DISCLOSURE:

"Safe Harbor" statement under the Private Securities Litigation Reform Act of
1995: This press release contains forward-looking statements that are subject to
risk and uncertainties, including, but not limited to, the impact of competitive
products, product demand, market acceptance risks, fluctuations in operating
results, political risk and other risks detailed from time to time in PharmaCom
BioVet, Inc.'s filings with the Securities and Exchange Commission. These risks
could cause PharmaCom BioVet, Inc.'s actual results to differ materially from
those expressed in any forward-looking statements made by, or on behalf of,
PharmaCom BioVet, Inc.





Contact:

Market Ideas, Inc.

877-295-3981 ext. 2

[e-mail]





SOURCE: PharmaCom BioVet, Inc.




CONTACT: mailto:[e-mail]




Copyright 2008 Market Wire, All rights reserved.

-0-




SUBJECT CODE: Lifestyle and Leisure:Family

Lifestyle and Leisure:Home and Garden

Lifestyle and Leisure:Women's Interest

Medical and Healthcare:Surgery and Treatments

Medical and Healthcare:Health and Nutrition

Medical and Healthcare:Healthcare

Medical and Healthcare:Facilities and Providers